0001493152-24-011569.txt : 20240327 0001493152-24-011569.hdr.sgml : 20240327 20240327175335 ACCESSION NUMBER: 0001493152-24-011569 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240325 FILED AS OF DATE: 20240327 DATE AS OF CHANGE: 20240327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MacPherson Edward Clouston CENTRAL INDEX KEY: 0002015989 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41765 FILM NUMBER: 24792392 MAIL ADDRESS: STREET 1: MIRA PHARMACEUTICALS, INC. STREET 2: 1200 BRICKELL AVENUE, SUITE 1950 #1183 CITY: MIAMI STATE: FL ZIP: 33131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001904286 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853354547 STATE OF INCORPORATION: FL BUSINESS ADDRESS: STREET 1: 1200 BRICKELL AVENUE STREET 2: SUITE 1950 #1183 CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 813-369-5150 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 FORMER COMPANY: FORMER CONFORMED NAME: Mira1a Therapeutics, Inc. DATE OF NAME CHANGE: 20220112 4 1 ownership.xml X0508 4 2024-03-25 0 0001904286 MIRA PHARMACEUTICALS, INC. MIRA 0002015989 MacPherson Edward Clouston C/O MIRA PHARMACEUTICALS, INC. 1200 BRICKELL AVENUE, SUITE 1950 #1183 MIAMI FL 33131 1 0 0 0 0 Nonqualified Stock Option (right to buy) 1.16 2024-03-25 4 A 0 50000 0 A 2034-03-25 Common Stock 50000 25000 D The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025. /s/ Edward MacPherson 2024-03-27